0
Orgenesis Inc. Banner Image

Orgenesis Inc.

  • Ticker ORGS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Orgenesis Inc. Logo Image
  • 201-500 Employees
  • Based in Germantown, Maryland
Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCareMore Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies.
REPORT RATINGS
4.8 / 5.0 (269)

Orgenesis Inc. reports have an aggregate usefulness score of 4.8 based on 269 reviews.

Orgenesis Inc.

Most Recent Annual Report

Orgenesis Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Orgenesis Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!